S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

(2016) Cindy Strehl et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab as induction therapy in relapsing eosinophilic granulomatosis with polyangiitis: A report of 6 cases

(2016) Pavel Novikov et al.   JOINT BONE SPINE

Improved survival in granulomatosis with polyangiitis: A general population-based study

(2016) Zachary S. Wallace et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease

(2016) Rennie L. Rhee et al.   Arthritis & Rheumatology

Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

(2016) Xavier Puéchal et al.   Arthritis & Rheumatology

Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

(2016) Rodrigo Cartin-Ceba et al.   Arthritis & Rheumatology

Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients

(2016) Etienne Crickx et al.   Arthritis & Rheumatology

Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association–European Dialysis and Transplant Association Registry

(2015) Zdenka Hruskova et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

(2015) Sebastian Unizony et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

(2015) Rachel B Jones et al.   ANNALS OF THE RHEUMATIC DISEASES

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group

(2015) Gonzalo de Luna et al.   JOURNAL OF AUTOIMMUNITY

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis

(2015) Lisa S Jeffs et al.   NEPHROLOGY

Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort

(2015) Jan H. Schirmer et al.   RHEUMATOLOGY

Reanalysis of the Rituximab in ANCA-Associated Vasculitis trial identifies granulocyte subsets as a novel early marker of successful treatment

(2015) Mazen Nasrallah et al.   ARTHRITIS RESEARCH & THERAPY

Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated With Glucocorticoids

(2015) E. M. Miloslavsky et al.   Arthritis & Rheumatology

Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013

(2015) Chinar Rahmattulla et al.   Arthritis & Rheumatology

Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty-Five Years or Older: Results of a Multicenter, Open-Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide-Based Induction Therapy

(2015) Christian Pagnoux et al.   Arthritis & Rheumatology

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

(2014) A J Mohammad et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis

(2014) W. F. Pendergraft et al.   Clinical Journal of the American Society of Nephrology

Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters

(2014) Z. Chocova et al.   CLINICAL RHEUMATOLOGY

Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: A systematic review and network meta-analysis

(2014) Glen S. Hazlewood et al.   JOINT BONE SPINE

Avoiding pitfalls in open augmentation rhinoplasty with autologous L-shaped costal cartilage strut grafts for saddle nose collapse due to autoimmune disease: The Cambridge experience

(2014) S.Y. Qian et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Granulomatosis With Polyangiitis (Wegener’s)

(2014) Jason Springer et al.   MEDICINE

Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors

(2014) Anisha Tanna et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Survival of patients with ANCA-associated vasculitis on chronic dialysis: data from the French REIN registry from 2002 to 2011

(2014) M. Romeu et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials

(2014) J. Robson et al.   RHEUMATOLOGY

Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis

(2014) Federico Alberici et al.   RHEUMATOLOGY

Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis

(2014) Emilio Besada et al.   RHEUMATOLOGY

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

(2014) K. Herlyn et al.   RHEUMATOLOGY

Induction treatment of ANCA-associated vasculitis with a single dose of rituximab

(2014) T. Turner-Stokes et al.   RHEUMATOLOGY

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

(2014) Eleana Ntatsaki et al.   RHEUMATOLOGY

High Risk of Pulmonary Embolism and Deep Venous Thrombosis but Not of Stroke in Granulomatosis With Polyangiitis (Wegener's)

(2014) Mikkel Faurschou et al.   ARTHRITIS CARE & RESEARCH

Predictors of Treatment Resistance and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 439 Cases in a Single Chinese Center

(2014) Zhi-Ying Li et al.   Arthritis & Rheumatology

Brief Report: Prevalence of Antineutrophil Cytoplasmic Antibodies in Infective Endocarditis

(2014) Alfred Mahr et al.   Arthritis & Rheumatology

Rituximab for the Treatment of Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2014) E. M. Miloslavsky et al.   Arthritis & Rheumatology

Rituximab With or Without a Conventional Maintenance Agent in the Treatment of Relapsing Granulomatosis With Polyangiitis (Wegener's): A Retrospective Single-Center Study

(2014) Lama Azar et al.   Arthritis & Rheumatology

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

Targeting Interleukin-5 in Refractory and Relapsing Churg–Strauss Syndrome

(2013) Frank Moosig et al.   ANNALS OF INTERNAL MEDICINE

The characterisation and determinants of quality of life in ANCA associated vasculitis

(2013) Neil Basu et al.   ANNALS OF THE RHEUMATIC DISEASES

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials

(2013) Joanna Robson et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

(2013) E. M. Miloslavsky et al.   ARTHRITIS AND RHEUMATISM

Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener’s)

(2013) Antonella Radice et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation

(2013) Helena Marco et al.   CLINICAL TRANSPLANTATION

Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis

(2013) Sarah Moran et al.   CURRENT OPINION IN RHEUMATOLOGY

Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) enrolled in two prospective trials

(2013) Maxime Samson et al.   JOURNAL OF AUTOIMMUNITY

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

(2013) Michael Walsh et al.   KIDNEY INTERNATIONAL

Subglottic stenosis: A ten-year review of treatment outcomes

(2013) Anne F. Hseu et al.   LARYNGOSCOPE

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

(2013) Ulrich Specks et al.   NEW ENGLAND JOURNAL OF MEDICINE

Orbital masses in granulomatosis with polyangiitis are associated with a refractory course and a high burden of local damage

(2013) Julia U. Holle et al.   RHEUMATOLOGY

Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre

(2013) Emilio Besada et al.   RHEUMATOLOGY

Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients

(2013) P. Charles et al.   RHEUMATOLOGY

Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study

(2013) Z Hruskova et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Predictors for Outcomes in Patients with Severe ANCA-associated Glomerulonephritis who were Dialysis-dependent at Presentation: A Study of 89 Cases in a Single Chinese Center

(2013) Zhi-Ying Li et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

(2013) Michael Walsh et al.   Trials

Impfempfehlungen der Kommission für Pharmakotherapie der DGRh

(2013) K. Warnatz et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Impfung bei erwachsenen Patienten mit chronisch entzündlichen rheumatischen Erkrankungen

(2013) S. Goldacker et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

(2013) Jens Thiel et al.   ARTHRITIS RESEARCH & THERAPY

New treatment of subglottic stenosis due to Wegener's granulomatosis

(2012) Julia Arebro et al.   ACTA OTO-LARYNGOLOGICA

A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

(2012) Frank Moosig et al.   ANNALS OF THE RHEUMATIC DISEASES

Brief Report: Long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Mikkel Faurschou et al.   ARTHRITIS AND RHEUMATISM

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

(2012) Rodrigo Cartin-Ceba et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Rona M. Smith et al.   ARTHRITIS AND RHEUMATISM

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

(2012) Cloé Comarmond et al.   ARTHRITIS AND RHEUMATISM

Classification of antineutrophil cytoplasmic autoantibody vasculitides: The role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis

(2012) Sophia Lionaki et al.   ARTHRITIS AND RHEUMATISM

Efficacy and Safety of Rituximab Treatment in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: Results from a German Registry (GRAID)

(2012) P. ROLL et al.   JOURNAL OF RHEUMATOLOGY

Effects of Mycophenolate Mofetil Combined with Corticosteroids for Induction Therapy of Microscopic Polyangiitis

(2011) Fei Han et al.   AMERICAN JOURNAL OF NEPHROLOGY

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

(2011) Lorraine Harper et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

(2011) Julia U Holle et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials

(2011) C. Heijl et al.   ANNALS OF THE RHEUMATIC DISEASES

Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides

(2011) Guillaume Le Guenno et al.   ARTHRITIS AND RHEUMATISM

Late-onset neutropenia following rituximab therapy in rheumatic diseases: Association with B lymphocyte depletion and infections

(2011) Daniel Tesfa et al.   ARTHRITIS AND RHEUMATISM

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS AND RHEUMATISM

Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: Report of 31 cases and review of the literature

(2011) Guillermo J. Pons-Estel et al.   AUTOIMMUNITY REVIEWS

Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease

(2011) J. G. McGregor et al.   Clinical Journal of the American Society of Nephrology

The Course of Asthma in Churg–Strauss Syndrome

(2011) Wojciech Szczeklik et al.   JOURNAL OF ASTHMA

Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

(2011) C. ROUBAUD-BAUDRON et al.   JOURNAL OF RHEUMATOLOGY

Airway reconstruction in Wegener's granulomatosis-associated laryngotracheal stenosis

(2011) Jacob L. Wester et al.   LARYNGOSCOPE

The Five-Factor Score Revisited

(2011) Loïc Guillevin et al.   MEDICINE

Rituximab for the treatment of Churg-Strauss syndrome with renal involvement

(2011) R. Cartin-Ceba et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab in Refractory Ophthalmic Wegener's Granulomatosis

(2011) Lavnish Joshi et al.   OPHTHALMOLOGY

Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence

(2011) Luis Corral-Gudino et al.   RHEUMATOLOGY

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

(2011) G. Tomasson et al.   RHEUMATOLOGY

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multicenter Experience

(2011) Duvuru Geetha et al.   TRANSPLANTATION

Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)

(2011) Megan E. B. Clowse et al.   ARTHRITIS CARE & RESEARCH

A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis

(2011) Ravi Suppiah et al.   ARTHRITIS CARE & RESEARCH

Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's)

(2011) Gunnar Tomasson et al.   ARTHRITIS CARE & RESEARCH

Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis

(2010) Michael Walsh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial

(2010) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

(2010) J. U. Holle et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term patient survival in ANCA-associated vasculitis

(2010) O. Flossmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients

(2010) Camillo Ribi et al.   ARTHRITIS AND RHEUMATISM

The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis

(2010) Randi Y. Leavitt et al.   ARTHRITIS AND RHEUMATISM

Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

(2010) Julia U. Holle et al.   ARTHRITIS AND RHEUMATISM

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

(2010) Alfonse T. Masi et al.   ARTHRITIS AND RHEUMATISM

Mycophenolate Mofetil for Induction and Maintenance of Remission in Microscopic Polyangiitis with Mild to Moderate Renal Involvement--A Prospective, Open-Label Pilot Trial

(2010) F. Silva et al.   Clinical Journal of the American Society of Nephrology

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2010) Thomas F. Hiemstra et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome

(2010) Sophia Kim et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Histopathologic Classification of ANCA-Associated Glomerulonephritis

(2010) A. E. Berden et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A CD8+ T cell transcription signature predicts prognosis in autoimmune disease

(2010) Eoin F McKinney et al.   NATURE MEDICINE

Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis--a clinical randomized controlled trial

(2010) W. M. Szpirt et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Addition of Infliximab to Standard Therapy for ANCA-Associated Vasculitis

(2010) Matthew D. Morgan et al.   NEPHRON CLINICAL PRACTICE

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Predictors at diagnosis of a first Wegener's granulomatosis relapse after obtaining complete remission

(2010) C. Pierrot-Deseilligny Despujol et al.   RHEUMATOLOGY

Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: A meta-analysis

(2010) Michael Walsh et al.   ARTHRITIS CARE & RESEARCH

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis

(2009) M. A. Little et al.   ANNALS OF THE RHEUMATIC DISEASES

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis

(2009) Simon R. J. Taylor et al.   ARTHRITIS AND RHEUMATISM

Health-related quality of life for patients with vasculitis and their spouses

(2009) Delesha M. Carpenter et al.   ARTHRITIS AND RHEUMATISM

Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: A matched-pair cohort study

(2009) Matthew D. Morgan et al.   ARTHRITIS AND RHEUMATISM

Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis

(2009) Mikkel Faurschou et al.   ARTHRITIS AND RHEUMATISM

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data-driven review

(2009) Paul A. Monach et al.   ARTHRITIS AND RHEUMATISM

Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial

(2009) Clifton O. Bingham et al.   ARTHRITIS AND RHEUMATISM

B-cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study

(2009) M. Martinez Del Pero et al.   CLINICAL OTOLARYNGOLOGY

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis

(2009) G. E. Tzelepis et al.   EUROPEAN RESPIRATORY JOURNAL

Ovarian Preservation by GnRH Agonists during Chemotherapy: A Meta-Analysis

(2009) Megan E.B. Clowse et al.   JOURNAL OF WOMENS HEALTH

Sinonasal Wegener granulomatosis: A single-institution experience with 120 cases

(2009) Steven B. Cannady et al.   LARYNGOSCOPE

Deoxyspergualin in relapsing and refractory Wegener's granulomatosis

(2008) O Flossmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination

(2008) A Holvast et al.   ANNALS OF THE RHEUMATIC DISEASES

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

(2008) P A Merkel et al.   ANNALS OF THE RHEUMATIC DISEASES

High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients

(2008) Y Allenbach et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of Churg-Strauss syndrome without poor-prognosis factors: A multicenter, prospective, randomized, open-label study of seventy-two patients

(2008) Camillo Ribi et al.   ARTHRITIS AND RHEUMATISM

Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis

(2008) Christian Pagnoux et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population

(2008) Y. Takizawa et al.   RHEUMATOLOGY

Longitudinale Effekte des strukturierten Patientenschulungsprogramms für Vaskulitispatienten

(2008) K. Herlyn et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Results of endoscopic surgery and intralesional steroid therapy for airway compromise due to tracheobronchial Wegener's granulomatosis

(2007) S A R Nouraei et al.   THORAX

Development of comprehensive disease assessment in systemic vasculitis

(2006) O Flossmann et al.   POSTGRADUATE MEDICAL JOURNAL